Haemonetics Corp - ESG Rating & Company Profile powered by AI
Complete Sustainability assessment of Haemonetics Corp are accessed by registering for free. This webpage is a free E,S&G analysis for Haemonetics Corp. The assessment of Haemonetics Corp incorporates data points from across the web as well as from public filings by Haemonetics Corp.
Haemonetics Corp in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 1.3, social score of 1.1 and governance score of 1.3.
1.2
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
... | ... | ... | |
332 | Shanghai Rightongene Biotechnology Co Ltd | 1.3 | Low |
332 | United Health Products Inc | 1.3 | Low |
341 | Haemonetics Corp | 1.2 | Low |
341 | Steris Corp | 1.2 | Low |
341 | Qatari German Company for Medical Devices QPSC | 1.2 | Low |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Haemonetics Corp have an accelerator or VC vehicle to help deliver innovation?
Does Haemonetics Corp disclose current and historical energy intensity?
Does Haemonetics Corp report the average age of the workforce?
Does Haemonetics Corp reference operational or capital allocation in relation to climate change?
Does Haemonetics Corp disclose its ethnicity pay gap?
Does Haemonetics Corp disclose cybersecurity risks?
Does Haemonetics Corp offer flexible work?
Does Haemonetics Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Haemonetics Corp disclose the number of employees in R&D functions?
Does Haemonetics Corp conduct supply chain audits?
Does Haemonetics Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Haemonetics Corp conduct 360 degree staff reviews?
Does Haemonetics Corp disclose the individual responsible for D&I?
Does Haemonetics Corp disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Haemonetics Corp disclose current and / or historical scope 2 emissions?
Does Haemonetics Corp disclose water use targets?
Does Haemonetics Corp have careers partnerships with academic institutions?
Did Haemonetics Corp have a product recall in the last two years?
Does Haemonetics Corp disclose incidents of discrimination?
Does Haemonetics Corp allow for Work Councils/Collective Agreements to be formed?
Has Haemonetics Corp issued a profit warning in the past 24 months?
Does Haemonetics Corp disclose parental leave metrics?
Does Haemonetics Corp disclose climate scenario or pathway analysis?
Does Haemonetics Corp disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Haemonetics Corp disclose the pay ratio of women to men?
Does Haemonetics Corp support suppliers with sustainability related research and development?
Does Haemonetics Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Haemonetics Corp reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Haemonetics Corp involved in embryonic stem cell research?
Does Haemonetics Corp disclose GHG and Air Emissions intensity?
Does Haemonetics Corp disclose its waste policy?
Does Haemonetics Corp report according to TCFD requirements?
Does Haemonetics Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Haemonetics Corp disclose energy use targets?
Does Haemonetics Corp disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Haemonetics Corp have a policy relating to cyber security?
Have a different question?
Potential Risks for Haemonetics Corp
These potential risks are based on the size, segment and geographies of the company.
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions; and Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries. It markets and sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.